Advertisement
Advertisement
U.S. markets close in 2 hours 21 minutes
Advertisement
Advertisement
Advertisement
Advertisement

Grifols, S.A. (GRFS)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
10.84-1.13 (-9.44%)
As of 01:39PM EDT. Market open.
Advertisement
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bearishpattern detected
Price Crosses Moving Average

Price Crosses Moving Average

Previous Close11.97
Open11.52
Bid10.90 x 900
Ask10.91 x 1100
Day's Range10.77 - 11.52
52 Week Range10.10 - 17.09
Volume1,114,320
Avg. Volume869,766
Market Cap9.763B
Beta (5Y Monthly)0.17
PE Ratio (TTM)38.71
EPS (TTM)0.28
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateJun 03, 2021
1y Target Est16.45
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
Undervalued
94% Est. Return

Subscribe to Yahoo Finance Plus to view Fair Value for GRFS

View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • Grifols, S.A.
    Analyst Report: Grifols, S.A.As a vertically integrated plasma derivative producer, Spain-based Grifols collects plasma and then manufactures and sells plasma-derived products globally. By acquiring Talecris in 2011, Grifols dramatically expanded its plasma-derived product portfolio, and the firm's bioscience business contributed 77% of sales in 2021. Grifols also has smaller segments including diagnostics, hospital supplies, and biosupplies. Diagnostics is now roughly 15% of revenue following the Novartis and Hologic deals.
    Rating
    Fair Value
    Economic Moat
    2 months agoMorningstar
View more
Advertisement
Advertisement